In the midst of Immunization for the past weeks, The Department of Health shared that it was incidentally ending the utilization of the AstraZeneca immunization on those matured 60 and underneath, following the suggestion of the Food and Drug Administration. The suggestion was because of worries over late reports of uncommon instances of blood clots with low platelets identified in …